Evidence map›Paper›PMID 25890070›Full record

ArticleHealth and quality of life outcomes2015

The impact of pediatric blood and marrow transplant on parents: introduction of the parent impact scale.

Katherine E Heinze, Angie Mae Rodday, Marie T Nolan, Kristin Bingen, Mary Jo Kupst, Sunita K Patel, Karen Syrjala, Lynnette Harris, Christopher Recklitis, Lisa Schwartz and 5 more

Open access · goldAbstract read
In one paragraph

Article in Health and quality of life outcomes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 1 country.

Katherine E HeinzeJohns Hopkins University School of Nursing, 525 N Wolfe Street, Baltimore, MD, 21205, USA. kgriff12@jhu.edu.
Angie Mae RoddayTufts Medical Center, 800 Washington Street #345, Boston, MA, 02111, USA. arodday@tuftsmedicalcenter.org.
Marie T NolanJohns Hopkins University School of Nursing, 525 N Wolfe Street, Baltimore, MD, 21205, USA. mnolan3@jhu.edu.
Kristin BingenMedical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. kbingen@mcw.edu.
Mary Jo KupstMedical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. mkupst@mcw.edu.
Sunita K PatelCity of Hope, 1500 E. Duarte Road, Duarte, CA, 91010, USA. supatel@coh.org.
Karen SyrjalaFred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA, 98109, USA. ksyrjala@fhcrc.org.
Lynnette HarrisBaylor College of Medicine, One Baylor Plaza, Baylor, TX, 77030, USA. llhari1@texaschildrens.org.
Christopher RecklitisDana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Christopher_Recklitis@dfci.harvard.edu.
Lisa SchwartzUniversity of Pennsylvania School of Medicine, 3501 Civic Center Boulevard CTRB 10311, Philadelphia, PA, 19104, USA. schwartzl@chop.email.edu.
Stella DaviesCincinnati Children's Hospital Medical Center, 3333 Burnett Avenue, Cincinnati, OH, 45229, USA. Stella.davies@cchmc.org.
Eva C GuinanDana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. eva_gunian@dfci.harvard.edu.
Robert NollChildren's Hospital of Pittsburgh of PUMC, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA. Robert.noll@chp.edu.
Grace ChangDepartment of Psychiatry, Harvard Medical School, Boston, MA, 02115, USA. Grace.chang2@va.gov.
Susan K ParsonsTufts Medical Center, 800 Washington Street #345, Boston, MA, 02111, USA. sparsons@tuftsmedicalcenter.org.
Dana-Farber Cancer Institute · USJohns Hopkins University · USMedical College of Wisconsin · USTufts Medical Center · USBaylor College of Medicine · USChildren's Hospital of Pittsburgh · USCincinnati Children's Hospital Medical Center · USCity of Hope · USFred Hutch Cancer Center · USHarvard University · USUniversity of Pennsylvania · US

Funding

Internet Studies to Enhance Long Term Survivorship after Hematologic MalignancyR01CA160684 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SYRJALA, KAREN LESLIE · 2011 to 2015
$3.4M
HSCT-CHESS to Enhance Hematopoietic Transplant RecoveryR01CA119196 · NCI · TUFTS MEDICAL CENTER · PI PARSONS, SUSAN KENYON · 2006 to 2010
$3.1M
Interdisciplinary Studies to Enhance Long Term SurvivalR01CA112631 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SYRJALA, KAREN LESLIE · 2005 to 2010
$2.8M
Parent and Family Responses to a Child Undergoing BMT During Transitions in CareF31NR014751 · NINR · JOHNS HOPKINS UNIVERSITY · PI HEINZE, KATHERINE · 2014 to 2015
$86k
NCI NIH HHS R01 CA112631NCI NIH HHS R01 CA119196NCI NIH HHS R01 CA160684NINR NIH HHS F31 NR014751NINR NIH HHS F31 NR014751-01A1
6 · The paper itself

Abstract

backgroundParents often experience stress-related complications when their child requires blood and marrow transplant (BMT). Previous studies have described the emotional toll BMT places on parents during the acute phase of care and within the context of clinical complications. In this paper we introduce the Parent Impact Scale (PARimpact), designed to capture physical and emotional challenges of the child's health on the parent. The primary aim of this paper is to examine psychometric properties of PARimpact, and the secondary aim is to explore factors associated with PARimpact scores for further hypothesis generation.

methodsThis analysis used a merged dataset of two longitudinal studies. Accompanying parents (n = 363) of children undergoing BMT were surveyed up to six times from pre-BMT baseline to one year after their child's BMT. For this analysis, pre-BMT baseline responses to PARimpact were used to examine the factor structure with Principal Component Analysis (PCA) and Exploratory Factor Analysis (EFA). Construct validity was assessed, and multivariable regression was used to examine relationships between PARimpact and BMT clinical variables.

resultsPCA and EFA revealed a one-factor solution with acceptable item loading; Cronbach's α was 0.83 at baseline. Hypothesized differences in known groups were detected for BMT complications with significantly higher PARimpact scores for those with vs. without each complication. In the adjusted multivariable regression models, acute graft versus host disease (b = 5.3; p = 0.03), end organ toxicity (b = 5.9; p < 0.01), and systemic infection (b = 9.1; p < 0.01) were associated with significantly higher mean PARimpact scores in the first 3 months following transplant. After the first 3 months to 1 year post BMT, systemic infection was associated with increased mean PARimpact scores (b = 19.2; p < 0.01).

conclusionsInitial results suggest that the PARimpact is valid and reliable. Our finding that clinical complications increase the impact of BMT on the caretaking parent indicates the need for BMT healthcare professionals to identify these events and help parents navigate the BMT course. Clinical application of the PARimpact scale should be considered to identify high-risk families and provide targeted interventions to augment care.

Indexed as

Stress, PsychologicalAdultBlood TransfusionBone Marrow TransplantationChildChild, PreschoolChild WelfareData CollectionEmotionsFactor Analysis, StatisticalFemaleHumansInfantLongitudinal StudiesMaleMiddle Aged

Identifiers

PMID25890070
PMCPMC4408604
OpenAlexW1973290729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.